natural killer cells

Athenex files for bankruptcy, seeks buyer for natural killer cell therapy unit
Athenex files for bankruptcy, seeks buyer for natural killer cell therapy unit
Fierce Biotech
Athenex
bankruptcy
natural killer cells
Flag link:
Gamida lays off 17%, ditches NK cell therapy work to keep blood cancer drug on track
Gamida lays off 17%, ditches NK cell therapy work to keep blood cancer drug on track
Fierce Biotech
Gamida Cell
layoffs
omidubicel
natural killer cells
Flag link:
Sanofi expands on Innate tumor collab with fresh $1.44B deal for more NK engagers
Sanofi expands on Innate tumor collab with fresh $1.44B deal for more NK engagers
Fierce Biotech
Sanofi
Innate Pharma
natural killer cells
solid tumors
Flag link:
Gilead dives deeper into NK cell therapies with Dragonfly deal
Gilead dives deeper into NK cell therapies with Dragonfly deal
Pharmaforum
Gilead Sciences
natural killer cells
Dragonfly Therapeutics
TriNKET
cancer
Flag link:
Nkarta: at least as good as Fate, at a tenth of the price
Nkarta: at least as good as Fate, at a tenth of the price
EP Vantage
Nkarta
Fate Therapeutics
natural killer cells
Flag link:
AACR 2022 – Affimed shows that 2021 was no fluke
AACR 2022 – Affimed shows that 2021 was no fluke
EP Vantage
AACR
Affimed
AFM13
natural killer cells
Flag link:
Cancer biotech Indapta nabs $50M for new approach to natural killer cell therapy
Cancer biotech Indapta nabs $50M for new approach to natural killer cell therapy
MedCity News
Indapta
natural killer cells
Flag link:
ASH: Senti Bio's gene circuit CAR-NK cell therapy enhances cancer killing and safety in leukemia models
ASH: Senti Bio's gene circuit CAR-NK cell therapy enhances cancer killing and safety in leukemia models
Fierce Biotech
Senti Biosciences
natural killer cells
AML
CAR-NK
Flag link:
Fate delivers, up to a point
Fate delivers, up to a point
EP Vantage
Fate Therapeutics
natural killer cells
CAR-NK
FT596
Flag link:
Nkarta keeps natural killer therapy ball rolling with plans for new San Francisco headquarters, manufacturing site
Nkarta keeps natural killer therapy ball rolling with plans for new San Francisco headquarters, manufacturing site
Fierce Pharma
Nkarta Therapeutics
natural killer cells
San Francisco
Flag link:
In a move to boost its natural killer candidates, Senti Bio will build out its own San Francisco manufacturing facility
In a move to boost its natural killer candidates, Senti Bio will build out its own San Francisco manufacturing facility
Endpoints
Senti Biosciences
natural killer cells
drug manufacturing
Flag link:
BeiGene dives in on natural killer cells with discovery pact for small biotech's stem cell-based platform
BeiGene dives in on natural killer cells with discovery pact for small biotech's stem cell-based platform
Endpoints
BeiGene
China
natural killer cells
cell therapy
Shoreline Biosciences
Flag link:
Celularity Gains FDA Orphan Drug Status on Strength of Placental Stem Cell Trials
Celularity Gains FDA Orphan Drug Status on Strength of Placental Stem Cell Trials
BioSpace
Celularity
FDA
orphan drugs
natural killer cells
malignant glioma
Flag link:
Nantkwest tries to catch the NK cell wave
Nantkwest tries to catch the NK cell wave
EP Vantage
NantKwest
natural killer cells
pancreatic cancer
Flag link:
Catamaran Bio sails into the CAR-NK waters with a $42M launch round
Catamaran Bio sails into the CAR-NK waters with a $42M launch round
Endpoints
Catamaran Bio
CAR-NK
funding
natural killer cells
Flag link:
Trying to turn 'natural killers' against cancer, Nkarta raises $114 million
Trying to turn 'natural killers' against cancer, Nkarta raises $114 million
Bizjournals
Nkarta Therapeutics
IPOs
cancer
natural killer cells
CAR-T
Flag link: